The Botswana Vaccine Institute (BVI) is a veterinary research institute owned by the Botswana government that carries out research on communicable diseases in domestic animals, with emphasis on viral transmitted infections.
BVI manufactures vaccines against major animal diseases for use in Botswana and for sale in 16 African and Middle Eastern countries.
[1] The headquarters and main offices of BVI are located in Broadhurst Industrial Park, 6385/90 Lejara Road, in the city of Gaborone, the capital of Botswana.
Over time, BVI forged a partnership with Merial, the French pharmaceutical conglomerate.
[1][3][4][5] In February 2024, BVI and the Uganda Ministry of Agriculture, Animal Industry and Fisheries, began collaboration to manufacture a type-specific vaccine for FMD suitable for Uganda, for control of the disease and the prevention of future outbreaks.